Current therapeutic options in the treatment of rheumatoid arthritis
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints. Untreated RA leads to a destruction of joints through the erosion of cartilage and bone. The loss of physical function is the consequence. Early treatment is important to control disease a...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 June 2019
|
| In: |
Journal of Clinical Medicine
Year: 2019, Volume: 8, Issue: 7 |
| ISSN: | 2077-0383 |
| DOI: | 10.3390/jcm8070938 |
| Online Access: | Verlag, Volltext: https://doi.org/10.3390/jcm8070938 Verlag, Volltext: https://www.mdpi.com/2077-0383/8/7/938 
|
| Author Notes: | Birgit M. Köhler, Janine Günther, Dorothee Kaudewitz and Hanns-Martin Lorenz |
| Summary: | Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints. Untreated RA leads to a destruction of joints through the erosion of cartilage and bone. The loss of physical function is the consequence. Early treatment is important to control disease activity and to prevent joint destruction. Nowadays, different classes of drugs with different modes of action are available to control the inflammation and to achieve remission. In this review, we want to discuss differences and similarities of these different drugs. |
|---|---|
| Item Description: | Published: 28 June 2019 Gesehen am 25.05.2020 |
| Physical Description: | Online Resource |
| ISSN: | 2077-0383 |
| DOI: | 10.3390/jcm8070938 |